180 related articles for article (PubMed ID: 21876965)
1. Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer.
Reis ST; Pontes-Júnior J; Antunes AA; Sousa-Canavez JM; Abe DK; Cruz JA; Dall'oglio MF; Crippa A; Passerotti CC; Ribeiro-Filho LA; Viana NI; Srougi M; Leite KR
Clinics (Sao Paulo); 2011; 66(7):1143-7. PubMed ID: 21876965
[TBL] [Abstract][Full Text] [Related]
2. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
[TBL] [Abstract][Full Text] [Related]
3. TGF Beta1 Expression Correlates with Survival and Tumor Aggressiveness of Prostate Cancer.
Wu CT; Chang YH; Lin WY; Chen WC; Chen MF
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1587-93. PubMed ID: 26271396
[TBL] [Abstract][Full Text] [Related]
4. Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer.
Reis ST; Antunes AA; Pontes-Junior J; Sousa-Canavez JM; Dall'Oglio MF; Piantino CB; Cruz JA; Morais DR; Srougi M; Leite KR
Int Braz J Urol; 2012; 38(2):167-74. PubMed ID: 22555040
[TBL] [Abstract][Full Text] [Related]
5. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
Shariat SF; Shalev M; Menesses-Diaz A; Kim IY; Kattan MW; Wheeler TM; Slawin KM
J Clin Oncol; 2001 Jun; 19(11):2856-64. PubMed ID: 11387358
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters.
Sinnreich O; Kratzsch J; Reichenbach A; Gläser C; Huse K; Birkenmeier G
Prostate; 2004 Nov; 61(3):201-8. PubMed ID: 15368477
[TBL] [Abstract][Full Text] [Related]
7. Research on the association of plasma TGF-β1 level and blood lymphocyte/monocyte ratio with pathological grade, clinical stage and prognosis of prostate cancer.
Wang Q; Ou T; Li J; Cui X; Liang J
J BUON; 2020; 25(5):2418-2423. PubMed ID: 33277864
[TBL] [Abstract][Full Text] [Related]
8. The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.
Kattan MW; Shariat SF; Andrews B; Zhu K; Canto E; Matsumoto K; Muramoto M; Scardino PT; Ohori M; Wheeler TM; Slawin KM
J Clin Oncol; 2003 Oct; 21(19):3573-9. PubMed ID: 12913106
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta as a clinical biomarker for prostate cancer.
Perry KT; Anthony CT; Case T; Steiner MS
Urology; 1997 Jan; 49(1):151-5. PubMed ID: 9000208
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
[TBL] [Abstract][Full Text] [Related]
13. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
[TBL] [Abstract][Full Text] [Related]
14. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.
Nariculam J; Freeman A; Bott S; Munson P; Cable N; Brookman-Amissah N; Williamson M; Kirby RS; Masters J; Feneley M
Asian J Androl; 2009 Jan; 11(1):109-18. PubMed ID: 19050681
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of transforming growth factor β1 in malignant prostate cells is partly caused by a runaway of TGF-β1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-β type I receptor.
Yu N; Kozlowski JM; Park II; Chen L; Zhang Q; Xu D; Doll JA; Crawford SE; Brendler CB; Lee C
Urology; 2010 Dec; 76(6):1519.e8-13. PubMed ID: 21030067
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
17. BZW1 promotes cell proliferation in prostate cancer by regulating TGF-β1/Smad pathway.
Shi Z; Xiao C; Lin T; Wu J; Li K
Cell Cycle; 2021 May; 20(9):894-902. PubMed ID: 33886419
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
19. TUG1 promotes the development of prostate cancer by regulating RLIM.
Guo BH; Zhao Q; Li HY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1926-1933. PubMed ID: 30915735
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer.
Kamoda N; Ohori M; Hirasawa Y; Inoue R; Hashimoto T; Satake N; Gondo T; Nakagami Y; Nagao T; Ohno Y
Jpn J Clin Oncol; 2019 Mar; 49(3):276-280. PubMed ID: 30649377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
